BREANNA BYRD: Open Payments
NPI 1750853198 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,084 in 38 payments from 25 companies in 2025. Trend: 2023 $1,508 · 2024 $1,429 · 2025 $1,084
Food & beverage: $1,084
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $146 |
| Novartis Pharmaceuticals Corporation | 7 | $141 |
| Novocure Inc. | 1 | $129 |
| Daiichi Sankyo Inc. | 3 | $84 |
| Regeneron Healthcare Solutions, Inc. | 2 | $71 |
| Celgene Corporation | 2 | $50 |
| Aveo Pharmaceuticals, Inc. | 1 | $42 |
| Eisai Inc. | 2 | $39 |
| Novo Nordisk Inc | 1 | $34 |
| Incyte Corporation | 1 | $27 |
Products named: Vyloy, Optune Lua (NovoTTF-200T), Enhertu, SCEMBLIX, LIBTAYO, REBLOZYL, FOTIVDA, Lenvima.
Industry payments across LA — which companies pay providers there.
